跳至主要内容
临床试验/NL-OMON23928
NL-OMON23928已完成不适用

A study on the efficacy of the combination of growth hormone and gonadotropin releasing hormone analogues (GnRHa) on adult height in children with idiopathic short stature.

Pfizer Inc, New York, through Dutch affiliate (Capelle a/d Ijssel) and Ferring (Denmark), through Dutch affiliate (Hoofddorp)0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40